JAMES PATRINELY to Immunotherapy
This is a "connection" page, showing publications JAMES PATRINELY has written about Immunotherapy.
Connection Strength
0.382
-
Association of Adjuvant Immunotherapy Duration With Chronic Immune-Related Adverse Events-Reply. JAMA Oncol. 2021 10 01; 7(10):1574-1575.
Score: 0.135
-
The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer. BioDrugs. 2020 Aug; 34(4):495-503.
Score: 0.124
-
Outcomes after progression of disease with anti-PD-1/PD-L1 therapy for patients with advanced melanoma. Cancer. 2020 08 01; 126(15):3448-3455.
Score: 0.123